Neuropharmacology and analgesiaIntrathecal Chlorprothixene (cas 113-59-7), cis(z)-flupenthixol, chlorpromazine and fluphenazine for prolonged spinal blockades of sensory and motor functions in rats
-
Add time:08/25/2019 Source:sciencedirect.com
The aim of this study was to examine whether thioxanthine-type antipsychotics (chlorprothixene and cis(z)-flupenthixol) and phenothiazine-type antipsychotics (chlorpromazine and fluphenazine) produced spinal anesthesia. Using a rat model of intrathecal injection, we evaluated spinal anesthesia of antipsychotic drugs (chlorprothixene, cis(z)-flupenthixol, chlorpromazine, and fluphenazine) and bupivacaine, a known local anesthetic. At a same dose of 2.31 μmol/kg, chlorprothixene had the most potent spinal blockades (P<0.001) and the longest duration of action (P<0.001) of motor function and nociception among those antipsychotic drugs. On the 50% effective dose (ED50) basis, the ranks of potencies were chlorprothixene=bupivacaine>cis(z)-flupenthixol>chlorpromazine>fluphenazine (P<0.01 for the differences) in dose–response studies. At an equianesthetic basis (ED25, ED50, and ED75), the spinal block duration caused by chlorprothixene, cis(z)-flupenthixol, chlorpromazine or fluphenazine was longer than that caused by bupivacaine (P<0.05). These results showed that chlorprothixene produced a similar potency and longer duration of spinal anesthesia than did bupivacaine, whereas several other antipsychotics produced less potency than did bupivacaine.
We also recommend Trading Suppliers and Manufacturers of Chlorprothixene (cas 113-59-7). Pls Click Website Link as below: cas 113-59-7 suppliers
Prev:Studying the fate of the drug Chlorprothixene (cas 113-59-7) and its photo transformation products in the aquatic environment: Identification, assessment and priority setting by application of a combination of experiments and various in silico assessments
Next:The management of postherpetic neuralgia with Chlorprothixene (cas 113-59-7)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Development of a liquid chromatographic method for the control of related substances in Chlorprothixene (cas 113-59-7) hydrochloride08/28/2019
- Determination of Chlorprothixene (cas 113-59-7) and amitryptyline hydrochlorides by UV-derivative spectrophotometry and UV-solid-phase spectrophotometry08/27/2019
- The management of postherpetic neuralgia with Chlorprothixene (cas 113-59-7)08/26/2019
- Studying the fate of the drug Chlorprothixene (cas 113-59-7) and its photo transformation products in the aquatic environment: Identification, assessment and priority setting by application of a combination of experiments and various in silico assessments08/24/2019
- A theoretical study of the structural and electronic properties of trans and cis structures of Chlorprothixene (cas 113-59-7) as a nano-drug08/23/2019
- Case reportChlorprothixene (cas 113-59-7) in bodies after exhumation08/22/2019
- Molecular and cellular pharmacologyThioxanthenes, Chlorprothixene (cas 113-59-7) and flupentixol inhibit proton currents in BV2 microglial cells08/21/2019
-
Health and Chemical more >
-
Related Products


